<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>endogenous retrovirus activation in cancer &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/endogenous-retrovirus-activation-in-cancer/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 08 Aug 2025 13:03:19 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>endogenous retrovirus activation in cancer &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>MUC1-C Links APOBEC3 and Retrovirus Activation in NSCLC</title>
		<link>https://bioengineer.org/muc1-c-links-apobec3-and-retrovirus-activation-in-nsclc/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 08 Aug 2025 13:03:19 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[cancer biology APOBEC3 retrovirus]]></category>
		<category><![CDATA[endogenous retrovirus activation in cancer]]></category>
		<category><![CDATA[genomic instability NSCLC]]></category>
		<category><![CDATA[MUC1-C and APOBEC3 interaction]]></category>
		<category><![CDATA[MUC1-C therapeutic targets]]></category>
		<guid isPermaLink="false">https://bioengineer.org/muc1-c-links-apobec3-and-retrovirus-activation-in-nsclc/</guid>

					<description><![CDATA[In a groundbreaking study published in Cell Death Discovery in 2025, researchers have unveiled a complex molecular interplay linking MUC1-C, a transmembrane oncoprotein, with the activation of APOBEC3 cytidine deaminases and endogenous retroviruses (ERVs) in non-small cell lung cancer (NSCLC) cells. This discovery sheds light on an intricate regulatory axis that fuels genome instability and [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">254678</post-id>	</item>
	</channel>
</rss>
